RedHill Biopharma (RDHL) Other Non-Current Assets (2012 - 2026)
RedHill Biopharma's Other Non-Current Assets was $99 million in the quarter ended Jun 30, 2026, compared with $160,000 a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Other Non-Current Assets (2012 - 2026) Analysis & Trends
As of Dec 31, 2025, Other Non-Current Assets at RedHill Biopharma came in at $169 million.
- Other Non-Current Assets shows a five-year compound annual growth rate of 59.9% (years ended Dec 2020 to Dec 2025).
- In earlier years, Other Non-Current Assets was $148,000 in the year ended Dec 31, 2024 (-81.3%), $790,000 in the year ended Dec 31, 2023 (-95.1%), $16 million in the year ended Dec 31, 2022 (-1.0%) and $16.17 million in the year ended Dec 31, 2021 (unchanged).
- Quarterly Other Non-Current Assets has moved between $148,000 (the quarter ended Dec 31, 2024) and $169 million (the quarter ended Dec 31, 2025) over five years.
- The best year-over-year quarter for Other Non-Current Assets over five years was the quarter ended Sep 30, 2021 (growth of 0.1%); the worst was the quarter ended Dec 31, 2023 (a decline of 95.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 9.94 Bn |
| 10 | RedHill Biopharma | 1.44 Mn | -15.18 Mn | - | 99.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 99.00 Mn |
| Dec 31, 2025 | 169.00 Mn |
| Jun 30, 2025 | 160,000.00 |
| Dec 31, 2024 | 148,000.00 |
| Jun 30, 2024 | 739,000.00 |
| Dec 31, 2023 | 790,000.00 |
| Jun 30, 2023 | 9.14 Mn |
| Mar 31, 2023 | 11.05 Mn |
| Dec 31, 2022 | 16.00 Mn |
| Sep 30, 2022 | 16.00 Mn |
| Jun 30, 2022 | 16.00 Mn |
| Mar 31, 2022 | 16.17 Mn |
| Dec 31, 2021 | 16.17 Mn |
| Sep 30, 2021 | 16.16 Mn |
| Jun 30, 2021 | 16.16 Mn |
| Mar 31, 2021 | 16.16 Mn |
| Dec 31, 2020 | 16.16 Mn |
| Sep 30, 2020 | 16.15 Mn |
| Jun 30, 2020 | 20.15 Mn |
| Mar 31, 2020 | 20.15 Mn |
API Access
RedHill Biopharma Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();